P09379 AF NFT

GTPase-activating protein GYP7

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidgmd2aajmennwya7femuyhkin6uteeunl3olgyvazh4mlhklk53m/metadata.json
IPFS of structure file: 
bafybeia2iwzn7plad7mv7awwbib52a45ax7dv5druxtuxobjiexqgplnse/AF-P09379-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xc4fEa86686f78821C47e9d275178fa19c66b7BCf
First NFT owner address (bech32): 
genesis1cnl2se5x77yzr3r7n5n4z786r8rxk770th8ky3
Current NFT ID #162585 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
162585
Accession (UniProt):
P09379
Name::
GTPase-activating protein GYP7
Experimental Method:
Predicted structure
Sequence source:
YARROWIA LIPOLYTICA (STRAIN CLIB 122 / E 150)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P09379 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P09379|GYP7_YARLI GTPase-activating protein GYP7 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=GYP7 PE=3 SV=2 MNSLWPVSVSHTQLTSINHQVYVHPTPSSKDNIPGFLALAKPRGATTDKEILVAWIPESKLQESAADFESYVKVDIKESGTPASSSLNLAETLVSPPPSSSFSSYAFSIPISDIFSLQVKQPSLGWWWGSITIHTRSKEDQLPPLYFHDAESQSTIMEQKRRNKKFETFDSESGSSMFWGGDHFIQVLSKYANLERAESDHSFLLVNPREGDAERFGTNLTGGSEEPSQLVAGIPGRGAGGDPVDRGAQVQKAFSDIRWGLLSNLAKVTQLTRKVSQGVWDSSPQPVKQLLMKPEVKKIGDDFDSARIYLAKWALSVAEESQRAKLKVLFDDELRELVSDEGFELIDAENNPQRRNEVSLAEWNAFFDYNGRLIVTVNEVKERIFHGGLAPAVRPEGWLFLLGVYPWDSTAAERKELVSKLRVDYNRLKKEWWVQEDKERDDFWRDQLSRIEKDVHRTDRNITFFAECDAKKDGDDDNYDKDEFGFSSQINSNIHLIQLRDMLITYNQHNKNLGYVQGMSDLLSPLYVVLQDDTLAFWAFSAFMERMERNYLRDQSGMRNQLLCLDHLVQFMLPSLYKHLEKTESTNLFFFFRMLLVWFKRELLWDDVLRLWEVLWTDYLSSQFVLFVCLAILDKHKDVMIDHLAGFDEILKYMNELSMTIDLDELLVRAELLFYRFRRTVELIDRKNEDRRNSADGSEPVSITEDLRELLSRKVIVVREGERPEGVMGG